Macular degeneration is the predominant cause of vision loss in the elderly. However, the word senile macular degeneration is often misinterpreted with respect to age-related macular degeneration (AMD or ARMD). The macula of the eye enables the central vision process. Macular degeneration occurs in dry and wet forms respectively. The dry form is the non-exudative form where as the wet form is the exudative form. In some instances, the advance of AMD is so slow that people may even fail to notice a little change in their vision. Whereas, in others the disease spreads faster and may lead to loss of vision in both the eyes.
Non-exudative Macular degeneration
The extra cellular deposits which are called drusen accumulate under the retinal pigment lead to the dry form. Although they appear pleomorphic, under ophthalmoscopy they generally tend to appear as discrete yellow lesions which are clustered in the macula referred to as pseudo papilledema. The symptoms of macular degeneration include difficulty in reading, recognizing faces etc. The peripheral vision remains but deteriorates gradually.
These lesions gradually become larger leading to multiple conditions such as retinal epithelial atrophy and also loss of photoreceptor function which causes vision loss. The enlargement of these lesions also results in retinal vein occlusion. Treatment with vitamins such as beta carotene, vitamin C and also zinc may slow down the process of dry macular degeneration.
Exudative Macular degeneration
The wet form or the exudative macular degeneration is a rare form of the disease. It occurs when the neovascular vessels arising from the choroid grow through defects in Bruch's membrane into the potential space of the retinal pigment epithelium. When these blood vessels leak, the retina is elevated along with the pigment epithelium leading to distorted or blurred form of vision. The symptoms resulting are generally gradual. However bleeding resulting from the sub retinal choroidal neovascular membranes may lead to acute vision loss. The exudative changes in the eye include hemorrhages, hard exudates, sub retinal / intraretinal fluid. Atrophy caused may be both incipient and geographic in nature. In addition to this, there is also a condition called central scotomas which is generally noticed as the missing areas of vision.
The neovascular membrane is difficult to locate by fundus examination since the locus of the membrane is beneath the retina. Angiography pertaining to the use of fluorescein or indocyanine may yield good diagnostic results. Laser ablation followed by the Angiography may prevent the onset of exudative macular degeneration.
Signs and symptoms of Macular degeneration
In gradual muscular degeneration, vision change is noticed slowly. The symptoms usually developed are:
Treatment of Macular degeneration
The wet from of macular degeneration is more likely to cause significant vision loss than the dry from and therefore different treatments for wet forms are available. These could help decrease the amount of vision lost. Laser treatment may stop or lesson vision loss in early stages of the disease. This is performed with specific wavelength designed to cauterize the abnormal blood vessels. A laser beam destroys blood vessels and may stop the growth of new ones. A scar forms after the treatment and this produces a permanent vision loss in that area of retina sacrificed to preserve the rest of the eye layer. Only a small number of people qualify for laser treatment and for many, vision may not improve after laser treatment. Photo dynamic therapy uses a light activated drug called verteportin given intravenously to the patient. A special laser is used to close the abnormal vessels while the retina is left intact. As closed blood vessels can reopen within a treated area, this may be necessary for one or two years. Exposure to light/sunlight should be avoided for five days after treatment. There are a number of drugs that block vascular endothelial growth factor and thus used as a treatment option. These have shown improvement in vision and not just delay or arrest the loss of vision due to macular degeneration.
Although macular degeneration is associated with age, genes related to the degeneration process of the macula have much significance. Factors such as obesity, hypertension, and oxidative stress may cause macular degeneration. Cardiovascular disease may increase the risk of macular degeneration. Among all the risk factors, smoking is considered as the most potent cause of macular degeneration. The risk of this disease in smokers is three times more than the other factors.
The macula is a vital part of the retina that is responsible for our central vision. It is involved in processing the light rays entering the central vision field. It is rich in cells called cones that convert light rays into impulses that travel through the optic nerve to the brain. Macular vision is about fine details, color and reading. Macular vision is intrinsic to our good vision. Problems in macular vision are usually due to drying out of certain areas of the macula or wet patches. Macular degeneration happens largely due to aging. Dry Macular degeneration or non-exudative macular degeneration is what is mostly noticed. It does not cause as much damage as wet macular degeneration. Symptoms of dry macular degeneration appear gradually and there is no treatment for this. Wet macular degeneration happens rather rapidly due to abnormal blood vessels in the retina. Photo dynamic therapy (laser) and anti-VEGF inhibitors are used to treat wet macular degeneration. Retinal photographs, visual acuity test, Amsler Grid and Fluorescein Angiography are tests that help determine macular vision problems.
Hormone Replacement Therapy
HRT involves administration of estrogen and progesterone hormones to counteract their dipping levels during menopause. Earlier ERT (Estrogen Replacement Therapy) was followed but this is now replaced by combined hormone therapy. HRT provides relief from symptoms such as increased fatigue and irritability and depression. Hormone Replacement Therapy is usually followed for a few months or a couple of years.
HRT is known to prevent or alleviate any bone loss that leads to osteoporosis. Women who have been on HRT experience enhanced sexuality and improved pelvic floor muscles. It may prove beneficial in preventing Alzheimer's disease and macular degeneration. Cyclic hormone therapy involves taking estrogen pills for 25 days, switching to progestin in between 10 - 14 days and then taking a combined pill for the next 25 days. Stopping the HRT for about 4 days brings on the menstrual bleeding.
The other form of administering HRT is continuos or combined therapy - whereby estrogen and progestin are taken everyday in combined form. Women on HRT complain of a bloated feeling as well as terrible headaches and fluid retention.
HRT Side Effects Some women experience post-menopausal bleeding when on HRT. Tender and swollen breast are yet another side effect of HRT. Swelling of the legs and increased weight are also noticed by women on HRT. Other associated risks of HRT are increased incidence of venous thrombosis or worsening of any existing liver condition. Long-term use of HRT is associated with breast cancer.
An HRT patch is an alternative to hormone tablets and vaginal creams. When ingested in tablet form, the hormone moves from the stomach and intestines to your liver. This necessitates higher dose of estrogen to be administered. HRT patches allow the skin to absorb estrogen through the bloodstream. HRT patches are worn on any location below your waist.
But it must never be applied on or near the breasts. Women suffering from sore or irritated skin must not use HRT patches. Vaginal creams containing estrogen are yet another method of administering HRT. This reduces the feeling of dryness experienced by most peri-menopausal women.
Bibliography / Reference
Collection of Pages - Last revised Date: July 20, 2018